Chris Cox Email
Director, Translational Sciences @ Accession Therapeutics Limited
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Chris Cox Location
- Wantage, GB
Chris Cox Work
- Director, Translational Sciences @ (November 2023 - Present)
- Head of Clinical Assays @ (June 2018 - July 2023)
- Senior Principal Scientist - Translational Medicine @ (July 2023 - November 2023)
- Head of Clinical Assays @ (June 2018 - July 2023)
- Senior Analytical Scientist @ (May 2015 - June 2018)
- UK Business Manager @ SGS Life Science Services (M-Scan and Vitrology) (January 2014 - December 2014)
- Biopharmaceutical Consultant @ Self-employed (August 2012 - January 2014)
- Managing Director, BioPharma Services, Europe @ Merck Millipore (November 2010 - August 2012)
- Director of Clinical Services @ (August 2009 - October 2010)
- Director of Clinical Services @ BioAnaLab (January 2003 - January 2009)
- Section Head Protein and Immunochemistry @ Covance Laboratories (January 1996 - January 2003)
- Post Doctoral Research Fellow @ (May 1993 - August 1996)
- MLSO Clinical Biochemistry @ Leicester Royal Infirmary (January 1988 - September 1989)
Chris Cox Education
- University of Lancashire
PhD (Cellular Physiology)
1989-1993
Chris Cox Skills
- Biopharmaceuticals
- Assay Development
- CRO
- Pharmaceutical Industry
- Biotechnology
- Biochemistry
- Protein Chemistry
- Life Sciences
- GLP
- Laboratory
- Validation
- Biomarkers
- Lifesciences
- Drug Discovery
- GMP
- Immunology
- ELISA
- Immunoassays
- Clinical Development
- Bioanalysis
- Clinical Trials
- Vaccines
- Drug Development
- Infectious Diseases
- Cell Based Assays
- Cell Culture
- Antibodies
- Technology Transfer
- Pharmacokinetics
- Cell
- Oncology
- Pharmaceuticals
- Flow Cytometry
- GCP
- Clinical Research
- Business Development
- Business Strategy
- Business Planning
- Process Improvement
- SOP
- Regulatory Requirements
- 21 CFR Part 11
- GxP
- Monoclonal Antibodies
- Start-ups
- Training
- Gene Therapy
- Good Laboratory Practice (GLP)
- CRO Management
- Leadership
- Development
- Good Laboratory Practice Glp
- Sales
- Start Ups
- Strategic Planning
- Molecular Biology
- Laboratory Skills
- Customer Service
- Management
- Research
- Good Laboratory Practice
Chris Cox Summary
- Chris Cox, based in Wantage, GB, is currently a Director, Translational Sciences at Accession Therapeutics Limited. Chris Cox brings experience from previous roles at Akamis Bio, PsiOxus Therapeutics Ltd and NIGHTSTARX LIMITED. Chris Cox holds a 1989 - 1993 PhD in Cellular Physiology @ University of Lancashire. With a robust skill set that includes Biopharmaceuticals, Assay Development, CRO, Pharmaceutical Industry, Biotechnology and more. Chris Cox has 2 emails on RocketReach.
Looking for a different Chris Cox?
Find contact details for 700 million professionals.
Others Named Chris Cox
Chris Cox
Chief Executive Officer
Shepperton, GB
Chris Cox
Managing Director, Real Assets Strategy
Toronto, ON, CA
Chris Cox
Founder and CEO
Reno, NV, US
Chris Cox
Founder | CEO
Rockwall, TX, US
Chris Cox
Chief Executive Officer
Frisco, TX, US
Chris Cox
President and CEO
Fairview Heights, IL, US
Top Accession Therapeutics Limited Employees
Bent Jakobsen
Founder and CEO
Oxford, GB
David Krige
Chief Development Officer (CDO)
Oxford, GB
Andy Johnson
Head of CMC
Oxford, GB
Stephanie Bewick
Chief Business Officer
Oxford, GB
Chris Cox
Director, Translational Sciences
Wantage, GB
Rita Figueiredo
Director Research Strategy
Oxford, GB
Ryea Maswood
Principal Scientist - CMC
Oxford, GB
Emily Trimby
Senior Scientist
Horspath, GB
Thomas Webb
Senior Scientist
Cardiff, GB
Sarah Kernaghan
Clinical Study Manager
London, England, GB
Nick Cross
Chairman of the Board
Dry Sandford, GB
Tania Selas
Principal Scientist
Oxford, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co